Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Top 100 Drugs

Top 200 by sales

Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon

Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone

Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec

More A-K · More L-Z · By Class · UK Medicines

For Consumers

For Professionals

For Researchers

Announcements

Physician's Desk Reference (PDR)

Latest FDA New Drug Approvals

Bydureon
Bydureon (exenatide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic ...

Picato
Picato (ingenol mebutate) is an inducer of cell death indicated for the topical treatment of actinic keratosis.

Zetonna
Zetonna (ciclesonide) is corticosteroid nasal spray indicated for the treatment of symptoms associated with seasonal and perennial allergic ...

More...

Drugs in Development – Not yet approved

Adasuve
Adasuve (Staccato loxapine) is an anti-agitation therapeutic that combines Alexza's proprietary Staccato system with loxapine, an ...

dapagliflozin
Dapagliflozin is an investigational selective sodium-glucose cotransporter-2 inhibitor for the treatment of adults with type 2 diabetes ...

lorcaserin
Lorcaserin is a selective serotonin 2C receptor agonist in development for weight management, including weight loss and maintenance of ...

More...

Daily Medical News

RSS

Bydureon Approved for Type 2 Diabetes

FRIDAY, Jan. 27 -- Bydureon (exenatide extended release), Amylin Pharmaceuticals' long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration. The once-weekly injection will include a label warning that the drug caused certain thyroid tumors in rats, the Dow Jones news service reported. It's not known whether the drug causes such tumors in people,...

Inlyta Approved for Advanced Kidney Cancer

FRIDAY, Jan. 27 -- Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven't responded to another drug. Renal cell carcinoma is a form of kidney cancer that begins in tissue that lines the kidney's small tubes. Inlyta blocks proteins that help fuel tumor growth in this area, the FDA said in a news release. Six...

IV Acetaminophen Linked to More Child Overdoses

FRIDAY, Jan. 27 -- Following the U.S. Food Drug Administration's approval last year of an intravenous formulation of acetaminophen for fever and pain in a hospital setting, researchers warn that use of the preparation could lead to serious overdoses, particularly among the youngest patients. The problem: There is confusion over measurement guidelines -- milligrams vs. milliliters, to be specific...

More...

Latest Pharma Industry News

RSS

FDA Approves Bydureon - The First and Only Once-Weekly Treatment for Type 2 Diabetes

SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has approved Bydureon (exenatide extended-release for injectable suspension) – the first once-weekly treatment for type 2 diabetes. Bydureon is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and...

FDA Approves Inlyta for Advanced Renal Cell Carcinoma

FRIDAY, January 27, 2012 -- The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer. Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes in the kidney. Inlyta works by blocking certain proteins called...

FDA Approves Picato (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing

PARSIPPANY, N.J., January 25, 2012, 2012 /PRNewswire/ -- Leo Pharma announced today that the U.S. Food and Drug Administration (FDA) approved Picato (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment of actinic keratosis (AK). AK is a precancerous condition caused by cumulative sun exposure that has the potential to progress to squamous cell carcinoma (SCC), the second most...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Picato, Zetonna, Subsys, Edarbyclor, Anturol, Forfivo XL, Intermezzo, Eylea, Erwinaze, Jakafi ...also see new filings.

Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch

Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...

Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store

1st June, 2011 – We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more ...

Pill Identifier Update

We’ve updated our pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest an ...

See more blog posts or follow us on twitter.

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search: